Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

Compass Therapeutics, Inc. Common Stock (CMPX)

Biological Products, (no Disgnostic Substances)

https://www.compasstherapeutics.com

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases.

80 GUEST STREET
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/13/2020

Market Cap

159,603,240

Shares Outstanding

127,490,000

Weighted SO

127,486,326

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

IDYA --.--%

ANAB --.--%

MGTX --.--%

KROS --.--%

FIXX --.--%

GLUE --.--%

NAMS --.--%

IVA --.--%

CGEM --.--%

Beta

0.6250

Last Div

0.0000

Range

0.765-2.573

Chg

0.0050

Avg Vol

396085

Mkt Cap

159603240

Exch

NASDAQ

Country

US

Phone

617 500 8099

DCF Diff

0.9829

DCF

0.1771

Div Yield

0.0000

P/S

56.1193

EV Multiple

-2.6640

P/FV

1.0089

Div Yield %

0.0000

P/E

-3.4870

PEG

-0.6102

Payout

0.0000

Current Ratio

40.7426

Quick Ratio

40.7426

Cash Ratio

6.0812

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

166.5118

CCC

-166.5118

Gross Margin

0.3418

Op Margin

-18.7855

Pretax Margin

-15.9789

Net Margin

-15.9789

Eff Tax Rate

-0.0694

ROA

-0.2820

ROE

-0.2867

ROCE

-0.3398

NI/EBT

1.0000

EBT/EBIT

0.8506

EBIT/Rev

-18.7855

Debt Ratio

0.0088

D/E

0.0090

LT Debt/Cap

0.0012

Total Debt/Cap

0.0089

Int Coverage

-28.5091

CF/Debt

-29.9200

Equity Multi

1.0260

Rec Turnover

0.0000

Pay Turnover

2.1920

Inv Turnover

0.0000

FA Turnover

1.2863

Asset Turnover

0.0176

OCF/Share

-0.3095

FCF/Share

-0.3097

Cash/Share

1.1438

OCF/Sales

-14.8653

FCF/OCF

1.0007

CF Coverage

-29.9200

ST Coverage

-34.5400

CapEx Coverage

-1409.2333

Div&CapEx Cov

-1409.2333

P/BV

1.0089

P/B

1.0089

P/S

56.1193

P/E

-3.4870

P/FCF

-3.7725

P/OCF

-3.7483

P/CF

-3.7483

PEG

-0.6102

P/S

56.1193

EV Multiple

-2.6640

P/FV

1.0089

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

Revenue Product Segmentation